Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PCRX | ETON |
|---|---|---|
| Price | $25.20 | $54.88 |
| Change today | ▲ 1.78% | ▲ 0.20% |
| Market cap | $1.00B | $1.57B |
| Return, 3 months | -1.2% | +47.0% |
| Return, year to date | -2.6% | +224.5% |
| Return, 1 year | +7.6% | +162.2% |
| P/E (TTM) | 72.0 | 140.7 |
| P/B | 1.5 | 33.7 |
| P/E percentile vs own 5y | 68th | 97th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +6.2% | +98.6% |
| Net profit growth (YoY) | +196.0% | +547.9% |
| Gross margin | 79.2% | 57.9% |
| Operating margin | 2.5% | 15.4% |
| Net margin | 2.0% | 12.0% |
| Return on equity | 2.0% | 36.0% |
| Analyst target vs. price | +19.0% | +25.1% |
| Analyst buy share | 57% | 100% |
| RSI (14) | 51 | 48 |
| 30-day volatility | 28.1% | 59.3% |
| Max drawdown, 1 year | -28.2% | -36.2% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
